Blind spot in endocarditis guidelines:

Janina Trauth, Ulrich Matt, Thomas A Kohl, Stefan Niemann, Susanne Herold

Open access · goldAbstract readCase Reports

In one paragraph

Article in European heart journal. Case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

0.6field-weighted citation impact, top 28% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

DisseminatedASM case reports · 2026
Article
The State-of-the-Art ofHealthcare (Basel, Switzerland) · 2024
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Janina TrauthDepartment of Medicine V-Infectious Diseases, Justus-Liebig-University, Klinikstr 33, 35392 Giessen, Germany.ORCID https://orcid.org/0000-0002-1959-7295

Ulrich MattDepartment of Medicine V-Infectious Diseases, Justus-Liebig-University, Klinikstr 33, 35392 Giessen, Germany.

Thomas A KohlMolecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Borstel, Germany.

Stefan NiemannMolecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Borstel, Germany.

Susanne HeroldDepartment of Medicine V-Infectious Diseases, Justus-Liebig-University, Klinikstr 33, 35392 Giessen, Germany.

Justus-Liebig-Universität Gießen · DEGerman Center for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The recently published 2023 Duke-ISCVID Criteria for Infective Endocarditis for the first time consider mycobacteria (esp. Case summary: Our case series demonstrates a diagnostic pathway for mycobacterial endocarditis. Symptoms are unspecific, and standard microbiological testing does not result in identification of the causative agent (see Graphical Abstract); therefore patients require special microbiological and imaging diagnostics. One patient with early diagnosis and stringent antibiotic and surgical therapy survived. Two patients with disseminated infection at the time point of diagnosis had fatal outcomes. Discussion: The diagnostic approach in our small retrospective case series is in line with the new modified Duke criteria and underlines the diagnostic gap in the previous definitions. Outcome of

Indexed as

Case reportEndocarditisMycobacterium chimaeraNon-tuberculous mycobacteria

Identifiers

PMID37654802

DOI10.1093/ehjcr/ytad400

PMCPMC10468014

OpenAlexW4386007904

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.